
Hannah Deacon: Tributes to mum who changed cannabis law
Colleagues of a campaigner who fought for her son's epilepsy to be treated with cannabis have described her as an "articulate, inspirational and impassioned advocate" following her death.Hannah Deacon was diagnosed with cancer and announced six weeks ago she would be stepping back from some responsibilities. She died on Tuesday, aged 45.Professor Mike Barnes, who helped Ms Deacon secure the first medical cannabis prescription in the UK in 2018 for her son Alfie, said she had been passionate and dedicated to the cause."Hannah was one of the most capable people I've ever had the privilege to work with," he said.
"She was full of common sense, full of dedication to her family but also dedication to others whose children, particularly, were also suffering from [treatment] resistant epilepsy who would benefit from cannabis."Prof Barnes said about 75,000 people in the UK had been helped by medical cannabis as a result of her work and believed no-one else had achieved so much in so little time.She was responsible for not only changing the law but also for helping establish the infrastructure to ensure it was distributed to pharmacies, he explained, adding that she would wanted anyone who might benefit from medical cannabis to be able to access it through the NHS."It was a remarkable campaign back in 2018 that enabled doctors to prescribe medical cannabis as a benefit to so many people."Prof Barnes said Alfie hadn't experienced a single seizure in more than five years as a result of medical cannabis, when previously he suffered 300-400 a month.He added: "We shouldn't forget the law changed as a result of the children."
'She was a force of nature'
Ms Deacon founded a range of organisations, including the Medical Cannabis Clinicians Society to engage doctors and healthcare professionals, Medcan Family Foundation to support other parents and carers, and Maple Tree Consultants where she worked with industry to press for change and improved outcomes.She was also an active member of the Cannabis Industry Council.A joint statement issued by the organisation's co-chairs, Dr Callie Seaman and Jamie Bartley, alongside CEO, Mike Morgan-Giles, described Ms Deacon as "an inspiration and hero"."Hannah was an absolute force of nature, concerned with protecting the life chances of not just her own children but many others in similar situations," they said."It was clear to those of us who knew Hannah that she would stop at nothing to achieve this."
They added that it was "no exaggeration" to say that without her work, medical cannabis would likely not be legal in the UK today."She was an articulate, inspirational and impassioned advocate for change, regularly appearing on the media and meeting politicians to hold their feet to the fire," their statement continued."Hannah always had a funny, mischievous and positive outlook on life and this rubbed off on many of us."She was someone you wanted to be around, who lit up a room and made the world a better place."
'This woman was incredible'
Tonia Antoniazzi, who chairs the All-Party Parliamentary Group on Medical Cannabis on or under Prescription, said she had worked closely with Ms Deacon."The work she has done has changed the lives of so many young children living with epilepsy," she said."This woman was incredible."Leader of the House of Commons Lucy Powell said she recalled Ms Deacon's campaigning and the times when it was debated in the House of Commons."I can truly say that she has changed the lives of many, she's changed policy and her life will be long-remembered by many, many others," she added.
Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
3 hours ago
- The Independent
Chancellor unveils £6bn NHS funding after health-centred spending review
Some £6 billion will be spent on speeding up testing and treatment in the NHS, Rachel Reeves has announced, after she placed the health service at the heart of Government spending plans. The Chancellor unveiled the investment, which includes new scanners, ambulances and urgent treatment centres aimed at providing an extra four million appointments in England over the next five years, after Wednesday's spending review. The funding is aimed at reducing waiting lists and reaching Labour's 'milestone' of ensuring the health service carries out 92% of routine operations within 18 weeks. In the review, Ms Reeves set out day-to-day spending across Government for the next three years, as well as plans for capital investment over the next four years. The NHS and defence were seen as the winners from the settlement, as both will see higher than average rises in public spending. This comes at cost of squeezing the budgets of other Whitehall departments and experts have warned tax rises may be needed later this year. The Chancellor and Sir Keir Starmer both sought to portray the review as a 'new phase' for the Government, following the criticism Labour has faced during its first year in power, including over cuts to winter fuel allowance. Ms Reeves claimed the NHS had been 'put on its knees' as a result of under-investment by the previous government, adding: 'We are investing in Britain's renewal, and we will turn that around.' The new £6 billion investment will come from the capital settlement for the NHS and will also help to speed up diagnoses with scans and treatment available in places such as shopping centres and high streets. The scale of day-to-day spending for the NHS is akin to an extra £29 billion a year. In a broadcast interview on Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after the boost to NHS spending. But while health and defence have benefited from the review, the Home Office, Ministry of Housing, Communities and Local Government, Department for Culture, Media and Sport, Department for Transport and Department for the Environment, Food and Rural Affairs are all in line for real-terms cuts in day-to-day spending. The Foreign Office is also in line for real-terms cuts, mainly as a result of a reduction in the overseas aid budget, which was slashed as part of the commitment to boost defence spending to 2.6% of gross domestic product – including the intelligence agencies – from 2027. Ms Reeves acknowledged 'not everyone has been able to get exactly what they want' following Cabinet squabbling over departmental budgets. She said 'every penny' of the spending increases had been funded through the tax and borrowing changes she had announced in her first budget. The Chancellor also insisted she would not need to mount another tax raid to pay for her plans, but experts warned the money for the NHS might still not be enough and the Government is under international pressure to boost defence funding further. Paul Johnson, of the Institute for Fiscal Studies, described the hospital waiting times target as 'enormously ambitious', adding: 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' At a summit later this month Nato members will consider calls to increase spending to 3.5% on defence, with a future 1.5% on defence-related measures. Steven Millard, interim director of the NIESR economic research institute, said the Chancellor's non-negotiable fiscal rules, coupled with the 'small amount of headroom' in her spending plans, meant 'it is now almost inevitable that if she is to keep to her fiscal rules, she will have to raise taxes in the autumn budget'. Elsewhere, policing leaders warned forces may need to make deep cuts after their settlement was announced. The spending review provides more than £2 billion for forces, but ministers have acknowledged some of that 'spending power' will come from council tax hikes.


Scottish Sun
3 hours ago
- Scottish Sun
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys GENERATION K Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Advertisement 1 Addiction to ketamine has risen eight-fold in a decade, experts have warned Credit: Getty Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Advertisement Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Advertisement Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.


The Sun
3 hours ago
- The Sun
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.